Farther Finance Advisors’s Maze Therapeutics MAZE Stock Holding History

Farther Finance Advisors’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.51K	Sell	326 -33	-9%	-$865	﹤0.01%	4451
2026 Q1	$10.4K	Hold	359	–	–	﹤0.01%	4083
2025 Q4	$14.9K	Sell	359 -24	-6%	-$825	﹤0.01%	3635
2025 Q3	$9.93K	Buy	+383	New	+$6.47K	﹤0.01%	3447

Other funds holding MAZE

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FWP

Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Farther Finance Advisors's MAZE Position: Q2 2026 in Review

Farther Finance Advisors reduced its Maze Therapeutics (MAZE) stake by 9.2% in Q2 2026, selling an estimated $865 and leaving 326 shares worth $9.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4451.

Farther Finance Advisors first reported a position in MAZE in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.9K in Q4 2025. 8 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

Farther Finance Advisors held 326 shares of Maze Therapeutics worth $9.51K as of Q2 2026.
Farther Finance Advisors sold 33 Maze Therapeutics shares in Q2 2026, an estimated $865.
Maze Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4451 holding.
Farther Finance Advisors first reported a position in Maze Therapeutics in Q3 2025 and has held it in 4 quarters since.
Farther Finance Advisors's Maze Therapeutics position peaked at $14.9K in Q4 2025.
8 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.